Abeona Therapeutics
ABEO
80 hedge funds and large institutions have $93.4M invested in Abeona Therapeutics in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 20 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 22
10% more call options, than puts
Call options by funds: $215K | Put options by funds: $196K
0.51% less ownership
Funds ownership: 2.64% → 2.13% (-0.51%)
8% less funds holding
Funds holding: 87 → 80 (-7)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
48% less capital invested
Capital invested by funds: $180M → $93.4M (-$86.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.15M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.58M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.34M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$1.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$17.1M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$6.54M |
| 3 |
Millennium Management
New York
|
-$5.04M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.76M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.33M |
ABEO Hedge Fund Activity: Q1 2020 in Review
80 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2020, worth a combined $93.4M — down 48% from $180M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ABEO and 13 opened new positions — a net loss of 7 holders — while 22 trimmed existing stakes and 32 added.
The largest buyer was BlackRock, adding an estimated $3.15M. The largest seller was CVI Holdings, exiting entirely with an estimated $17.1M sold.
- 80 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2020, down from 87 in Q4 2019.
- Funds reported $93.4M of Abeona Therapeutics stock for Q1 2020, down 48% quarter-over-quarter.
- 13 funds opened new Abeona Therapeutics positions in Q1 2020 and 20 closed out, a net change of -7 holders.
- The largest Abeona Therapeutics buyer in Q1 2020 was BlackRock, an estimated $3.15M added.
- The largest Abeona Therapeutics seller in Q1 2020 was CVI Holdings, an estimated $17.1M sold.
Based on aggregated 13F filings for Q1 2020.